SomnoMed® Increases Investment in Managed Care Infrastructure
SomnoMed Limited (ASX: SOM), the global leader in oral appliance therapy for obstructive sleep apnea (OSA), today announced a significant investment in its managed care infrastructure to continue delivering high-quality support for health plan, provider network, and large-scale care program partnerships across the United States.
